Deputy Director, Office of Strategic Partnerships and Technology Innovation
U.S. Food and Drug Administration
Dr. Michelle Tarver is the Deputy Director of the Office of Strategic Partnerships and Technology Innovation where she helps provide leadership for all scientific collaborative and emerging technology-related activities at the Center for Devices and Radiological Health (CDRH). She provides leadership and oversight for CDRH in matters relating to public health emergency preparedness and response activities, digital health, cybersecurity, conformity standards development and implementation, partnerships, and patient science and engagement involving medical devices. Under her leadership, CDRH is advancing efforts to include diverse and underrepresented populations in the evaluation of medical devices. She also continues to advance inclusion of the patient perspective as the Program Director for Patient Science in the Digital Health Center of Excellence. As the lead of CDRH’s Strategic Priority on Collaborative Communities, she guides and facilitates collaboration in fostering the development and evaluation of innovative medical devices that can address unmet public health needs. Dr. Tarver attended Spelman College in Atlanta, GA where she received a B.S. in Biochemistry. She completed the M.D./Ph.D. program at The Johns Hopkins University Bloomberg School of Public Health (Ph.D. in clinical epidemiology) and The Johns Hopkins University School of Medicine. Following her internal medicine internship, she completed a residency in ophthalmology with fellowship training in ocular inflammation (uveitis) both at the Wilmer Eye Institute (Johns Hopkins). As an epidemiologist and board-certified ophthalmologist, she has worked on longitudinal epidemiological studies, clinical trials, registries, developing patient-reported outcome measures as well as surveys to capture patient preferences with medical devices. Her research has resulted in numerous peer-reviewed publications and published book chapters. As a dedicated clinician, she continues to evaluate and treat ophthalmology patients at Solomon Eye Associates in Bowie, MD.
Disclosure information not submitted.
Monday, September 12, 2022
3:30 PM – 4:30 PM MST